ASCO Issues Clinical Guidelines On Adjuvant Chemotherapy For Early Breast Cancer.

Medscape reported that the American Society of Clinical Oncology (ASCO) “issued comprehensive clinical guidelines on adjuvant chemotherapy for early breast cancer and targeted adjuvant therapy for HER2-positive breast cancer.” The “guidelines are largely adapted from the 2015 Cancer Care Ontario (CCO) clinical practice guidelines, with some additional guidance from ASCO.” The recommendations were published online in the Journal of Clinical Oncology.

© 2021 FLASCO | Premium Website Design by The HDG